Enterprise Products Partners L.P.

SEC Filings

ENTERPRISE PRODUCTS PARTNERS L P filed this Form 8-K on 02/07/2018
Entire Document

Interest Payment Dates During Floating Rate Period:    Quarterly in arrears on February 15, May 15, August 15 and November 15 of each year, beginning on May 15, 2028
CUSIP/ISIN:    29379VBR3 / US29379VBR33
Use of Proceeds:    EPO will receive aggregate net proceeds of approximately $691,760,000 from the sale of the notes to the underwriters after deducting the underwriting discount and other estimated offering expenses payable by EPO. EPO expects to use the net proceeds of this offering, together with the proceeds from the concurrent senior notes offering (as defined in the Preliminary Prospectus Supplement), if completed, for the repayment of debt, including the repayment of amounts outstanding under our commercial paper program and the repurchase or redemption of all or a portion of the Junior Subordinated Notes B (as defined in the Preliminary Prospectus Supplement), and for general company purposes.
Joint Book-Running Managers:   

J.P. Morgan Securities LLC


Merrill Lynch, Pierce, Fenner & Smith



Deutsche Bank Securities Inc.


Scotia Capital (USA) Inc.


DNB Markets, Inc.


Morgan Stanley & Co. LLC


SG Americas Securities, LLC


TD Securities (USA) LLC

Senior Co-Manager:    BBVA Securities Inc.

Barclays Capital Inc.


Citigroup Global Markets Inc.


Credit Suisse Securities (USA) LLC


Mizuho Securities USA Inc.


MUFG Securities Americas Inc.


RBC Capital Markets, LLC


SMBC Nikko Securities America, Inc.


SunTrust Robinson Humphrey, Inc.


U.S. Bancorp Investments, Inc.


Wells Fargo Securities, LLC


Schedule IV - 2